General Information of This Metabolic Reaction (MR) (ID:
MR013077) |
Formula |
|
Reactant |
Vonoprazan |
Product |
TAK-438 N-sulfate |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Sulfotransferase 2A1 (SULT2A1)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Sulfonation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Assessments of CYP?inhibition?based drug-drug interaction between vonoprazan and poziotinib in?vitro and in?vivo
|
2 |
In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker. Xenobiotica. 2017 Dec;47(12):1027-1034.
|
3 |
Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.